CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

4.931 -0.219 (-4.25%)

Streaming Delayed Price Updated: 2:54 PM EDT, Sep 25, 2026 Add to My Watchlist

Price and Volume

Volume	1,022
Open	5.210
Bid (Size)	4.850 (2,800)
Ask (Size)	5.240 (100)
Prev. Close	5.150
Today's Range	4.931 - 5.210
52wk Range	1.900 - 10.59
Shares Outstanding	620,290
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Injectable Nanodevices Exhibit Potency Against Brain Tumors

September 21, 2026

Via Investor Brand Network

Accelerated Biological Aging Could Explain Why Younger Adults are Getting Cancer

September 17, 2026

Via Investor Brand Network

Performance

YTD	-7.0%	-7.0%
1 Month	-15.0%	-15.0%
3 Month	+18.8%	+18.8%
6 Month	+92.6%	+92.6%
1 Year	-40.8%	-40.8%

More News

Laser Therapy Shows Promise in Treating Brain Cancer

September 08, 2026

Via Investor Brand Network

Timing of Brain Metastasis Predicts Survival of Colorectal Cancer Patients

September 04, 2026

Via Investor Brand Network

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Business Development Strategy in Virtual Investor Segment

September 01, 2026

Via Investor Brand Network

New T Cell Therapy Could Transform Glioblastoma Care

August 24, 2026

Via Investor Brand Network

Collagen Tiles Could Prevent Brain Cancer Recurrence

June 08, 2026

Via Investor Brand Network

CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

September 01, 2026

From CNS Pharmaceuticals, Inc.

Via ACCESS Newswire

Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients

August 27, 2026

Via Investor Brand Network

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Strategic Transformation at Virtual Investor Conference

August 27, 2026

Via Investor Brand Network

CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference

August 27, 2026

From CNS Pharmaceuticals, Inc.

Via ACCESS Newswire

Researchers Identify a Protein That Could Be Targeted in Glioblastoma Therapy

August 18, 2026

Via Investor Brand Network

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 Results as Strategic Pivot Advances

August 12, 2026

Via Investor Brand Network

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

August 12, 2026

From CNS Pharmaceuticals, Inc.

Via ACCESS Newswire

Focused Ultrasound Shows Promise in Treating Brain Tumors

August 10, 2026

Via Investor Brand Network

Spanish Patient Highlights Risks of Poorly Cooked Pork

August 07, 2026

Via Investor Brand Network

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

July 30, 2026

Via Investor Brand Network

Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer

July 27, 2026

Via Investor Brand Network

Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer

July 21, 2026

Via Investor Brand Network

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence

July 13, 2026

Via Investor Brand Network

New Vaccine Gives Brain Cancer Patients Hope of Longer Survival

July 10, 2026

Via Investor Brand Network

Scientists Find Targeting Enzyme That Could Block Brain Metastases

June 24, 2026

Via Investor Brand Network

WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment

June 23, 2026

Via Investor Brand Network

Study Links TBI to Higher Mortality Risk Due to Brain Cancer

June 12, 2026

Via Investor Brand Network

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation

June 08, 2026

Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?

CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market

What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?

The current price of CNS Pharmaceuticals, Inc. - Common Stock is 4.931

When was CNS Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 09/25/26 02:54 PM ET

What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?

The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 3.06M

How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?

CNS Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.